| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |